Forbion's 4th Life Sciences Fund Hits $417M In Final Close
European venture capital firm Forbion Capital Partners on Monday said it has closed its fourth life sciences venture capital fund at €360 million ($417 million), nearly three months after the oversubscribed...To view the full article, register now.
Already a subscriber? Click here to view full article